以植物为基础的肥胖症饮食综述。

IF 3.7 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Endocrine Practice Pub Date : 2024-08-01 DOI:10.1016/j.eprac.2024.04.020
{"title":"以植物为基础的肥胖症饮食综述。","authors":"","doi":"10.1016/j.eprac.2024.04.020","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>Obesity is the most prevalent chronic disease in the United States with over 70% of the American population suffering from overweight/obesity. Recently, the popularity of plant-based diets (PBDs) has grown, with individuals adopting these diets for ethical, health and environmental reasons. Our aim is to evaluate the effect of a PBD on weight loss among patients who are overweight or obese.</p></div><div><h3>Methods</h3><p>A literature review of PBDs for the treatment of obesity was conducted using PubMed and Scopus. Our search yielded 27 intervention trials (3361 participants) and 6 metanalyses (9168 participants, 61 trials).</p></div><div><h3>Results</h3><p>Among the intervention trials evaluated, 75% showed a significant increase in weight loss or decrease in weight in the intervention group, on average −5.0 kg (range −1.8 to −12.1 kg). Other outcomes included energy intake (−420 Kcal/d), systolic blood pressure (−3.78 mmHg), fasting plasma glucose (−2.0 mmol/L), hemoglobin A1c (−0.5%, −3.4 mmol/L), total cholesterol (−0.40 mmol/L), low-density lipoprotein (−0.38 mmol/L), triglyceride levels (+0.13 mmol/L), and fiber intake (+10.8 g/d). The 6 meta-analyses showed weight loss (average −2.9 kg, range −2.02 kg to −4.1 kg), body mass index reduction, and improvements in hemoglobin A1c, low-density lipoprotein, and total cholesterol.</p></div><div><h3>Conclusion</h3><p>PBDs result in significant weight loss and improve metabolic outcomes. PBDs offer a sustainable approach to long-term weight loss maintenance. Health care providers should encourage open discussions with their patients regarding their dietary habits to assist them in setting feasible lifestyle goals and consider shared medical appointments to support patients in transitioning to PBDs.</p></div>","PeriodicalId":11682,"journal":{"name":"Endocrine Practice","volume":null,"pages":null},"PeriodicalIF":3.7000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1530891X24005135/pdfft?md5=597f4fc3d2d38ed73e2402f3f60fc0e1&pid=1-s2.0-S1530891X24005135-main.pdf","citationCount":"0","resultStr":"{\"title\":\"A Review of Plant-Based Diets for Obesity Management\",\"authors\":\"\",\"doi\":\"10.1016/j.eprac.2024.04.020\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><p>Obesity is the most prevalent chronic disease in the United States with over 70% of the American population suffering from overweight/obesity. Recently, the popularity of plant-based diets (PBDs) has grown, with individuals adopting these diets for ethical, health and environmental reasons. Our aim is to evaluate the effect of a PBD on weight loss among patients who are overweight or obese.</p></div><div><h3>Methods</h3><p>A literature review of PBDs for the treatment of obesity was conducted using PubMed and Scopus. Our search yielded 27 intervention trials (3361 participants) and 6 metanalyses (9168 participants, 61 trials).</p></div><div><h3>Results</h3><p>Among the intervention trials evaluated, 75% showed a significant increase in weight loss or decrease in weight in the intervention group, on average −5.0 kg (range −1.8 to −12.1 kg). Other outcomes included energy intake (−420 Kcal/d), systolic blood pressure (−3.78 mmHg), fasting plasma glucose (−2.0 mmol/L), hemoglobin A1c (−0.5%, −3.4 mmol/L), total cholesterol (−0.40 mmol/L), low-density lipoprotein (−0.38 mmol/L), triglyceride levels (+0.13 mmol/L), and fiber intake (+10.8 g/d). The 6 meta-analyses showed weight loss (average −2.9 kg, range −2.02 kg to −4.1 kg), body mass index reduction, and improvements in hemoglobin A1c, low-density lipoprotein, and total cholesterol.</p></div><div><h3>Conclusion</h3><p>PBDs result in significant weight loss and improve metabolic outcomes. PBDs offer a sustainable approach to long-term weight loss maintenance. Health care providers should encourage open discussions with their patients regarding their dietary habits to assist them in setting feasible lifestyle goals and consider shared medical appointments to support patients in transitioning to PBDs.</p></div>\",\"PeriodicalId\":11682,\"journal\":{\"name\":\"Endocrine Practice\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2024-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S1530891X24005135/pdfft?md5=597f4fc3d2d38ed73e2402f3f60fc0e1&pid=1-s2.0-S1530891X24005135-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Endocrine Practice\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1530891X24005135\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrine Practice","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1530891X24005135","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

目标:肥胖症是美国最普遍的慢性疾病,超过 70% 的美国人患有超重/肥胖症。近来,植物性饮食越来越受欢迎,人们出于道德、健康和环保的原因采用这些饮食。我们的目的是评估植物性饮食(PBD)对超重或肥胖患者减肥的影响:方法:我们使用 PubMed 和 Scopus 对治疗肥胖症的植物基饮食进行了文献综述。搜索结果包括 27 项干预试验(3361 名参与者)和 6 项荟萃分析(9168 名参与者,61 项试验):结果:在接受评估的干预试验中,75%的试验表明干预组的体重明显下降,平均下降幅度为-5.0千克(范围为-1.8至-12.1千克)。其他结果包括能量摄入量(-420 千卡/天)、收缩压(-3.78 毫米汞柱)、空腹血浆葡萄糖(-2.0 毫摩尔/升)、HbA1c(-0.5%,-3.4 毫摩尔/升)、总胆固醇(-0.40 毫摩尔/升)、低密度脂蛋白(-0.38 毫摩尔/升)、甘油三酯水平(+0.13 毫摩尔/升)和纤维摄入量(+10.8 克/天)。六项荟萃分析表明体重减轻(平均-2.9 千克,范围-2.02 千克至-4.1 千克),体重指数降低,HbA1c、低密度脂蛋白和总胆固醇有所改善:结论:PBDs 可显著减轻体重并改善代谢结果。PBDs 为长期保持减肥效果提供了一种可持续的方法。医疗服务提供者应鼓励患者就其饮食习惯进行公开讨论,以帮助他们制定可行的生活方式目标,并考虑共享医疗预约,以支持患者过渡到 PBDs。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
A Review of Plant-Based Diets for Obesity Management

Objective

Obesity is the most prevalent chronic disease in the United States with over 70% of the American population suffering from overweight/obesity. Recently, the popularity of plant-based diets (PBDs) has grown, with individuals adopting these diets for ethical, health and environmental reasons. Our aim is to evaluate the effect of a PBD on weight loss among patients who are overweight or obese.

Methods

A literature review of PBDs for the treatment of obesity was conducted using PubMed and Scopus. Our search yielded 27 intervention trials (3361 participants) and 6 metanalyses (9168 participants, 61 trials).

Results

Among the intervention trials evaluated, 75% showed a significant increase in weight loss or decrease in weight in the intervention group, on average −5.0 kg (range −1.8 to −12.1 kg). Other outcomes included energy intake (−420 Kcal/d), systolic blood pressure (−3.78 mmHg), fasting plasma glucose (−2.0 mmol/L), hemoglobin A1c (−0.5%, −3.4 mmol/L), total cholesterol (−0.40 mmol/L), low-density lipoprotein (−0.38 mmol/L), triglyceride levels (+0.13 mmol/L), and fiber intake (+10.8 g/d). The 6 meta-analyses showed weight loss (average −2.9 kg, range −2.02 kg to −4.1 kg), body mass index reduction, and improvements in hemoglobin A1c, low-density lipoprotein, and total cholesterol.

Conclusion

PBDs result in significant weight loss and improve metabolic outcomes. PBDs offer a sustainable approach to long-term weight loss maintenance. Health care providers should encourage open discussions with their patients regarding their dietary habits to assist them in setting feasible lifestyle goals and consider shared medical appointments to support patients in transitioning to PBDs.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Endocrine Practice
Endocrine Practice ENDOCRINOLOGY & METABOLISM-
CiteScore
7.60
自引率
2.40%
发文量
546
审稿时长
41 days
期刊介绍: Endocrine Practice (ISSN: 1530-891X), a peer-reviewed journal published twelve times a year, is the official journal of the American Association of Clinical Endocrinologists (AACE). The primary mission of Endocrine Practice is to enhance the health care of patients with endocrine diseases through continuing education of practicing endocrinologists.
期刊最新文献
Suppressed Renin Status is a Risk Factor for Cardiocerebrovascular Events in Bilateral Primary Aldosteronism Treated with Mineralocorticoid Receptor Antagonists. Safety and efficacy of the novel RNA interference therapies for hypertriglyceridemia and mixed hyperlipidemia management: a systematic review and meta-analysis. Life's Essential 8 and Mortality in US Adults with Obesity: A Cohort Study. The history of thyroid ultrasound: Past, present, and future directions. Evaluating the risk of venous thromboembolism in transfeminine and gender diverse people: A retrospective analysis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1